Facebook
X
LinkedIn
ForwardTodd Morgan, MD
Todd M. Morgan, M.D. is Professor of Urology and Chief of Urologic Oncology at the University of Michigan, specializing in the evaluation and treatment of genitourinary malignancies. Dr. Morgan is a translational surgeon-scientist whose research spans preclinical laboratory-based research to prospective clinical trials. His laboratory primarily focuses on identifying clinically relevant molecular approaches to predict response and resistance to treatment in genitourinary malignancies. This includes work in prostate cancer to develop blood and bone marrow-based assays that can guide precision-based therapeutic strategies in real time, and he is principal investigator of two large randomized controlled trials evaluating tissue-based biomarkers in men with localized prostate cancer. Dr. Morgan has been the recipient of Young Investigator Awards from the Prostate Cancer Foundation, Society for Urological Oncology, National Comprehensive Cancer Network (NCCN), and Society for Basic Urology Research. He has served on a number of national guideline committees, such as the AUA Muscle-Invasive Bladder Cancer Guidelines, the AUA Advanced Prostate Cancer Guidelines, the NCCN Prostate Cancer Early Detection Guidelines, The ASCO Localized Prostate Cancer Guideline, and the ASCO Molecular Markers for Prostate Cancer Guidelines. His research is supported by multiple sources and includes funding from the Department of Defense, National Cancer Institute, and the Prostate Cancer Foundation
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:Myriad GeneticsDate added:Date updated:04/01/2021
-
Attribution:SelfType of financial relationship:OtherIneligible company:MDxHealthDate added:Date updated:04/01/2021